Regions Financial Corp Immuno Gen, Inc. Transaction History

Regions Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$5.02 - $6.59 $63,518 - $83,383	-12,653 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$5.79 - $8.6 $73,260 - $108,815	12,653 New	12,653 $83,000
Q2 2019 Jul 19, 2019	SELL	$1.8 - $3.3 $6,067 - $11,124	-3,371 Closed	0 $0
Q2 2018 Jul 26, 2018	SELL	$9.52 - $12.15 $1,761 - $2,247	-185 Reduced 5.2%	3,371 $33,000
Q4 2017 Jan 18, 2018	BUY	$5.07 - $7.92 $18,028 - $28,163	3,556	3,556 $23,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Regions Financial Corp with notifications on news.